FDA takes action against Abbvie for misleading Ubrelvy ad with Serena Williams
The Food and Drug Administration recently intervened regarding a migraine medication ad featuring tennis superstar Serena Williams.
FDA slams AbbVie for misleading claims in Serena Williams ad for migraine drug Ubrelvy
The FDA has faulted AbbVie’s promotion of the migraine drug Ubrelvy, calling the company out for an ad featuring Serena Williams that went out of bounds with claims about how quickly the product relieves symptoms.
AbbVie faulted for misleading ad featuring Serena Williams
In the ad for oral CGRP inhibitor Ubrelvy (ubrogepant), Williams is depicted as suffering from a migraine while in a talk show dressing room, which resolves by the time she walks onto the set and allows her to carry out the interview laughing and pain-free.
FDA scolds AbbVie over ‘misleading’ TV ad for a migraine pill featuring Serena Williams
The FDA has scolded AbbVie for making false and misleading claims about a TV ad about a migraine pill that features Serena Williams.
FDA sends letter to drugmaker, says ad featuring Serena Williams was misleading
A drugmaker's advertisement featuring Serena Williams is under FDA scrutiny for misleading claims that it can quickly cure migraine headaches.
FDA calls out AbbVie over ‘misleading’ commercial featuring Serena Williams
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
'Aint She Rich Enuf?': Serena Williams Under Fire as the FDA Steps In Following 'Misleading' Commercial for Migraine Medicine Maker
JD Supra1d
Ubrelvy Untitled Letter – A Double Fault for AbbVie? Or Makeup Misread for FDA?
The next frame shows the Ubrelvy logo in the backstage hallway along with a blue lit path. Frames six to seven then show Serena Williams walking down the blue lit path, no longer exhibiting migraine ...
FiercePharma9d
AbbVie's Ubrelvy to be top migraine seller in 2033
AbbVie’s migraine drug Ubrelvy (ubrogepant) is slated to be the top-selling drug in the migraine space in 2033 across the ...
Migraine Drug Ubrelvy May Stop Headaches Even Before They Start
A migraine drug can stop the devastating headache symptoms of migraines in their tracks, allowing sufferers to go about their ...
UPI21d
Migraine drug Ubrelvy may stop headaches at first sign
People who took ubrogepant (Ubrelvy) were 73% more likely to say they had no disability and were able to function normally within a couple of hours, compared to those who took a placebo ...
Healthline16d
Ubrelvy: Pregnancy and Breastfeeding Information
Ubrelvy (ubrogepant) is a prescription oral tablet that’s used for fast-acting relief of migraine symptoms in adults. Ubrelvy may not be safe to take while pregnant or breastfeeding. If you can ...